Emis Group Plc PT Raised to GBX 851 at Panmure Gordon (EMIS)
Equities research analysts at Panmure Gordon raised their price objective on shares of Emis Group Plc (LON:EMIS) from GBX 820 ($13.75) to GBX 851 ($14.27) in a research note issued to investors on Friday. The firm currently has a “buy” rating on the stock. Panmure Gordon’s price target indicates a potential upside of 13.34% from the company’s current price.
A number of other analysts have also recently weighed in on EMIS. Analysts at Westhouse Securities upgraded shares of Emis Group Plc to a “buy” rating in a research note on Friday. They now have a GBX 900 ($15.09) price target on the stock. Separately, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Emis Group Plc in a research note on Monday. They now have a GBX 860 ($14.42) price target on the stock. Finally, analysts at N+1 Singer raised their price target on shares of Emis Group Plc from GBX 748 ($12.54) to GBX 820 ($13.75) in a research note on Tuesday, May 20th. They now have a “buy” rating on the stock. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of GBX 802.71 ($13.46).
Emis Group Plc (LON:EMIS) traded up 3.19% during mid-day trading on Friday, hitting GBX 777.50. The stock had a trading volume of 21,012 shares. Emis Group Plc has a one year low of GBX 535.00 and a one year high of GBX 807.087. The stock has a 50-day moving average of GBX 663.7 and a 200-day moving average of GBX 626.7.
EMIS Group plc is engaged in the design of computer software for healthcare professions, mainly general practitioners and pharmacists also, together with the supply and support of computer systems for the healthcare profession and other users.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.